Kane Biotech Inc. KNBIF OTC

Kane Biotech Inc. (KNBIF) reported total assets of $2.74M and total liabilities of $3.53M for quarter ending 2025-09-30, resulting in total equity of $-793.37K.

The company held $939.06K in cash and short-term investments. Total debt stood at $2.3M, with net debt of $1.36M. The Debt-to-Equity (D/E) ratio was -2.9 (conservative).

Current ratio is 0.9, which may signal tight short-term liquidity. Interest coverage is -7.6x (weak).

Criteria supported by this page:

• HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
• MOAT (43/100) — Total assets $2.74M and equity $-793.37K support the company's competitive scale

Overall SharesGrow Score: 51/100 with 2/7 criteria passed.